Rosamond Deegan
Chief Executive Officer at OMass Therapeutics Ltd.
Network origin in Rosamond Deegan first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
OMass Therapeutics Ltd.
 OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom.
11
| Holding Company | Miscellaneous Commercial Services | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rosamond Deegan via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Chief Executive Officer | |
| PEPGEN INC. | Biotechnology | Director/Board Member | |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Consultant / Advisor | |
| The University of Manchester | College/University | Doctorate Degree | |
Macrophox Ltd.
 Macrophox Ltd. BiotechnologyHealth Technology Macrophox Ltd. engages in the provision of research and experimental development on biotechnology. The company was founded on March 12, 2018 and is headquartered in Woodstock, The United Kingdom. | Biotechnology | Chairman | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| GlaxoSmithKline (Pharmaceutical Operations) | Corporate Officer/Principal | ||
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Boston Consulting Group Ltd.
 The Boston Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group Ltd. provides management consulting services. Its capabilities includes corporate development and finance, postmerger integration, digital economy, risk management, globalization, strategy, innovation, growth, sustainability, marketing and sales, technology, operations, turnaround and transformation and people and organization. The company was founded in 1963 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Founder | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
Epiios Therapeutics GmbH
 Epiios Therapeutics GmbH Electronics DistributorsDistribution Services Epiios Therapeutics GmbH is a German company that markets pharmaceutical drug technologies. The private company is based in Berlin, Germany. | Electronics Distributors | Chief Executive Officer | |
Enzbond Ltd.
 Enzbond Ltd. Miscellaneous Commercial ServicesCommercial Services Enzbond Ltd. engages in research and development on natural sciences and engineering. The firm specializes in enzyme discovery. The company was founded by Alina Rakhimova and Robert Simion and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Depixus SAS
 Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Azeria Therapeutics Ltd.
 Azeria Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Azeria Therapeutics Ltd. engages in the research and development of pharmaceutical products. It develops treatments for hormone resistance that targets breast and prostate cancer patients. The company was founded by Jason Carroll in 2017 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pulmagen Therapeutics LLP
 Pulmagen Therapeutics LLP Pharmaceuticals: MajorHealth Technology Pulmagen Therapeutics Ltd. manufactures and develops respiratory drugs. Its services include pulmagen respiratory product pipeline, pulmagen crth2 antagonist product pipeline, new generation bronchodilators-astrazeneca collaboration, theocort-inhaled corticosteroid re-sensitisation, inhaled ppar gamma agonists and chiesi collaboration-anti-inflammatory agents. The company was founded in February 2010 and is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman | |
| Georgetown University | College/University | Undergraduate Degree | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member | |
Therapeutic Human Polyclonals, Inc.
 Therapeutic Human Polyclonals, Inc. Pharmaceuticals: MajorHealth Technology Therapeutic Human Polyclonals, Inc. develops human antibody therapeutics. Its technology will enable the generation of monoclonal and polyclonal antibody therapeutics. The company is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | President | |
| Bio Ventures for Global Health | Director/Board Member | ||
Joslin Diabetes Center, Inc.
 Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Yale Law School | College/University | Graduate Degree | |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Chairman | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman |
Statistics
International
| United States | 27 |
| United Kingdom | 20 |
| France | 3 |
| Germany | 2 |
| Netherlands | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 5 |
| Technology Services | 2 |
Operational
| Director/Board Member | 29 |
| Corporate Officer/Principal | 15 |
| Chairman | 12 |
| Independent Dir/Board Member | 9 |
| Chief Executive Officer | 9 |
Most connected contacts
- Stock Market
- Insiders
- Rosamond Deegan
- Company connections
